When a company acquires another business, there's often going to be a premium involved, especially if it's in good shape or has some promising assets in its portfolio. But normally, you don't see a company pay double what its current valuation is That's what Vertex
The Stock Market Just Sent Its Most Confusing Signal in Years -- but History Is Clear on What Happens Next The stock market just capped its most lucrative quarter in years, with the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) surging by more than 14% and...</strong
Warren Buffett aims to dispose of all his Berkshire Hathaway (BRK.A) (BRK.B) shares within about eight years. The legendary investor will convert 8,000 class A shares into 12M class B shares today, targeting the donation of the class B shares to Warren Buffett aims to disp
Oracle (NYSE: ORCL) is one of the most important companies in the global artificial intelligence (AI) infrastructure ecosystem, as it is aggressively building data centers to enable customers to run AI workloads in the cloud. However, the stock's performance has left much
Second-quarter results from both lenders exceeded analyst forecasts amid resilient economic activity. Bank of America and Wells Fargo reported second-quarter earnings that surpassed Wall Street expectations on Tuesday. The beats reflect sustained consumer spending and loan
Cummins (CMI) declares $2.20/share quarterly dividend, 10% increase from prior dividend of $2.00. - Forward yield 1.32% - Payable Sept. 3; for shareholders of record Aug. 21; ex-div Aug. 21. - See CMI Dividend Scorecard, Yield Chart, & Dividend Growth
Apple's (AAPL) lawsuit alleging that OpenAI (OPAI.PVT) stole trade secrets from the iPhone maker includes a number of major claims, ranging from OpenAI employees stealing sensitive files from Apple to an effort by employees to gain access to physical hardware. The suit, wh
Car-sharing firm Zoomcar narrows annual losses, reporting a 47% reduction in adjusted EBITDA and improved margins. Zoomcar Holdings (ZCAR) reported a 47% year-over-year reduction in its adjusted EBITDA loss for fiscal 2026. The company’s net loss attributable to shareholde
Proceeds from the 25M share offering will fund operations through topline data from a Phase 3 clinical study. Inhibikase Therapeutics sold 25M shares of common stock to RA Capital Management for $50M in gross proceeds. The transaction was executed through an at-the-market
TappAlpha Innovation 100 Growth & Daily Income ETF sets $0.39 payout for July, targeting a 17.03% annualized yield. TappAlpha Innovation 100 Growth & Daily Income ETF (TDAQ) announced a $0.39 per share monthly dividend, equating to a 17.03% forward yield. The dividend is p
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.